Institute of Medical Microbiology, University Hospital Münster, Münster, Germany.
Interdisciplinary Center for Clinical Research, Münster, Germany.
Front Immunol. 2019 Nov 5;10:2552. doi: 10.3389/fimmu.2019.02552. eCollection 2019.
is one of the first and most prevalent pathogens cultured from the airways of cystic fibrosis (CF) patients, which can persist there for extended periods. Airway infections in CF patients are characterized by a strong inflammatory response of highly recruited neutrophils. One killing mechanism of neutrophils is the formation of neutrophil extracellular traps (NETs), which capture and eradicate bacteria by extracellular fibers of neutrophil chromatin decorated with antimicrobial granule proteins. secretes nuclease, which can degrade NETs. We hypothesized, that adapts to the airways of CF patients during persistent infection by escaping from NET-mediated killing via an increase of nuclease activity. Sputum samples of CF patients with chronic infection were visualized by confocal microscopy after immuno-fluorescence staining for NET-specific markers, bacteria and overall DNA structures. Nuclease activity was analyzed in sequential isogenic long persisting isolates, as confirmed by whole genome sequencing, from an individual CF patient using a FRET-based nuclease activity assay. Additionally, some of these isolates were selected and analyzed by qRT-PCR to determine the expression of and regulators of interest. NET-killing assays were performed with clinical isolates to evaluate killing and bacterial survival depending on nuclease activity. To confirm the role of nuclease during NET-mediated killing, a clinical isolate with low nuclease activity was transformed with a nuclease expression vector (pCM28). Furthermore, two sputa from an individual CF patient were subjected to RNA-sequence analysis to evaluate the activity of nuclease . In sputa, was associated to extracellular DNA structures. Nuclease activity in clinical isolates increased in a time-and phenotype-dependent manner. In the clinical isolates, the expression of 1 was inversely correlated to the activity of and was independent of . NET-mediated killing was significantly higher in isolates with low compared to isolates with high nuclease activity. Importantly, transformation of the clinical isolate with low nuclease activity with pCM28 conferred protection against NET-mediated killing confirming the beneficial role of nuclease for protection against NETs. Also, nuclease expression in sputa was high, which underlines the important role of nuclease within the highly inflamed CF airways. In conclusion, our data show that adapts to the neutrophil-rich environment of CF airways with increasing nuclease expression most likely to avoid NET-killing during long-term persistence.
是囊性纤维化 (CF) 患者气道中最早和最普遍培养的病原体之一,它可以在那里持续存在很长时间。CF 患者的气道感染的特征是高度募集的中性粒细胞的强烈炎症反应。中性粒细胞的一种杀伤机制是形成中性粒细胞细胞外陷阱 (NETs),通过中性粒细胞染色质的细胞外纤维捕获和消除细菌,这些纤维上装饰有抗菌颗粒蛋白。 分泌核酸酶,可降解 NETs。我们假设, 在持续性感染期间通过增加核酸酶活性来逃避 NET 介导的杀伤从而适应 CF 患者的气道。对慢性 感染的 CF 患者的痰液样本进行免疫荧光染色,以显示 NET 特异性标记物、 细菌和整体 DNA 结构。通过全基因组测序确认来自单个 CF 患者的连续同源长持续 分离株的核酸酶活性,使用基于 FRET 的核酸酶活性测定法进行分析。此外,选择并分析了一些这些分离株,通过 qRT-PCR 确定 和感兴趣的调节剂的表达。使用临床 分离株进行 NET 杀伤测定,以评估依赖于核酸酶活性的杀伤和细菌存活。为了确认核酸酶在 NET 介导的杀伤中的作用,使用核酸酶表达载体 (pCM28) 转化具有低核酸酶活性的临床分离株。此外,从单个 CF 患者的两个痰液中进行 RNA 测序分析,以评估核酸酶 的活性。在痰液中, 与细胞外 DNA 结构相关。临床 分离株中的核酸酶活性呈时间和表型依赖性增加。在临床分离株中, 1 的表达与核酸酶的活性成反比,并且与 无关。与高核酸酶活性的分离株相比,低核酸酶活性的分离株的 NET 介导杀伤明显更高。重要的是,用 pCM28 转化具有低核酸酶活性的临床分离株赋予了对 NET 介导杀伤的保护,这证实了核酸酶在保护 NET 方面的有益作用。此外,在 痰液中核酸酶的表达很高,这突出了核酸酶在高度炎症性 CF 气道中的重要作用。总之,我们的数据表明, 通过增加核酸酶表达来适应 CF 气道中富含中性粒细胞的环境,这很可能是在长期持续存在期间避免 NET 杀伤的原因。